3 Stocks in a Tailspin

By Dave Mock | More Articles
July 31, 2009 | Comments (1)

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Individual stocks can surge 10%, 25%, or even higher in a short period of time. And they can fall just as far, just as quickly. For example, shares in soft-drink maker Cott fell nearly 27% on Monday after the company cut its full-year earnings outlook.

Big drops in share price can sometimes signal material defects or new risks. But at other times, they're simply pullbacks along with the larger pessimism facing the market today. Fortunately, we have Motley Fool CAPS, a great resource to help us understand the larger picture behind big price drops.

Is the sky falling?
CAPS contains more than just the crowd's opinions. Its best-performing members' votes count more in shaping each company's rating than do the picks of their poorer-performing peers. That way, investors can intelligently use the collective wisdom of more than 135,000 CAPS members to make better decisions.

We'll use CAPS' handy stock screening tool to quickly zero in on companies that have been slashed by at least 15% in the past four weeks, and which have a market cap greater than $100 million and a beta of less than 3. If you want to run this screen for yourself, please do -- just keep in mind that the results will update with the market.

Company	CAPS Rating (out of 5)	4-Week Price Change
CardioNet (Nasdaq: BEAT )	***	(22.3%)
Hansen Medical (Nasdaq: HNSN )	****	(23.2%)
Allegheny Technologies (NYSE: ATI )	****	(19.2%)

Source: Motley Fool CAPS. Price return July 2 through July 28.

CardioNet
While putting in one of the best new issue showings in 2008, shares of CardioNet are now trading well below last year's IPO price after the company recently withdrew its 2009 outlook and Pennsylvania Medicare carrier Highmark cut the reimbursement rate for CardioNet's cardiac monitoring services. The revision will likely put pressure on the company's revenue, which is strongly tied to rates it collects from health management organizations covering some of the cost for the implantation of its devices. Revenue from its MCOT system had grown to 88% of total revenue in the first quarter, and total revenue had increased by 40% over last year.

The stock price collapse isn't the only thing reflecting the evaporation of expected growth -- only 84% of the 151 CAPS members rating CardioNet today expect it to outperform the market.

Hansen Medical
While Intuitive Surgical (Nasdaq: ISRG ) smashed revenue and earnings estimates for its recent quarter, and medical-device maker Boston Scientific (NYSE: BSX ) also beat Wall Street forecasts, Hansen Medical recently estimated that its second-quarter revenue will fall well short of analyst expectations. Apparently, economic troubles have caused several customers to delay orders and reassess financing for its Sensei Robotic Catheter systems. On top of this, the company will face a challenge collecting the $36 million it was awarded in a suit against Luna Innovations, as Luna filed for Chapter 11 bankruptcy protection and is seeking to have the damages reduced significantly.

Despite all the gloom and doom, though, 95% of the 522 CAPS members rating Hansen Medical expect it to outperform the market.

Allegheny Technologies
Similar to steel producer AK Steel (NYSE: AKS ) , specialty metals producer Allegheny posted a loss for the second quarter, hurt by weak demand from the automotive and aerospace industries. Its revenue was cut in half to $710 million from $1.46 billion, and most of its segments felt pressure. It also expects a tough third quarter, with challenging pricing, in an environment that has seen other companies like Nucor (NYSE: NUE ) slash production since last year.

Despite the turmoil in the steel and metals sector, though, 95% of the 1,182 CAPS members rating Allegheny Technologies are still bullish.

Ultimately, whether you believe a fall in any stock is warranted, your own research is more important than collective opinions. CAPS can help you quickly focus your due diligence, and even point out potential pitfalls you may not have seen.

Add your take on these or any of the 5,300 stocks that 135,000-plus members have covered in Motley Fool CAPS. It's totally free to be a part of the community, and the payback is more than worth it.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Intuitive Surgical is one of dozens of stocks selected by the Motley Fool Rule Breakers service to beat the market over the long haul. To see all the stocks David Gardner and the analyst team have recommended, take a free 30-day trial today.

Fool contributor Dave Mock habitually looks for silver linings in even the darkest of clouds. He owns no shares of companies mentioned here. The Fool's disclosure policy is made of sugar and spice and everything nice.

Read/Post Comments (1) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Report this Comment On July 31, 2009, at 3:58 PM, nybuckaroo wrote:

Hansen Medical. The company has nearly $20,000m of Cash. That is the only good thing one can say about this train wreck of a company, the failed copycat of Intuitive Surgical (the leader and Rolls Royce of robotic instruments) Hansen was founded by Prof. Fred Moll, who helped found Intuitive and should have stayed there. The product is extremely expensive, not a good fact in times of hospital budget constraints. Furthermore, Intuitive already has a huge installed base. Hospitals ain't going to buy two robotic systems. But let's get back to some numbers. Contrast the $20,000m Cash against: Losses EVERY year of ($50,000m); Losses EVERY Qtr of ($14,000m); Accts Payable of over ($10,000m); Short Term Debt of over ($3,000m); and LT Debt of over ($9,000m). Hmmmm, don't think $20,000m is going to cover it. There are some astounding lawsuits against Hansen for patient injury. And orders are down. Another teardrop along the boulevard of broken dreams known as Wall Street.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 954879, ~/Articles/ArticleHandler.aspx, 5/25/2012 7:18:26 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
	DOW	12,454.83	-74.92	-0.60%
	S&P 500	1,317.82	-2.86	-0.22%
	NASD	2,837.53	-1.85	-0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes